Potential sale of KKR’s LGC expected to produce $3 bln-plus deal
The company serves customers across the biotech and pharmaceutical, clinical diagnostics, food, ag-bio and environment, and research and government markets.
16 August 2019•2 mins read
The company serves customers across the biotech and pharmaceutical, clinical diagnostics, food, ag-bio and environment, and research and government markets.
